HER2+ Metastatic Breast Cancer: An Evolving Treatment Armamentarium

Comprehensive insight on the treatment armamentarium currently available to patients with HER2+ metastatic breast cancer and CNS disease.

Related Videos
Ann H. Partridge, MD, MPH
Adrienne G. Waks, MD,
Erika P. Hamilton, MD
Aditya Bardia, MD, MPH
Sara M. Tolaney, MD, MPH
Expert on breast cancer
Expert on RCC
Experts on RCC
Expert on breast cancer
Related Content